Coronary artery disease detection: Pharmacologic stress SPECT

Clinical Nuclear Cardiology

Volumn , Issue , 2010, Pages 244-266

  Zoghbi, Gilbert J ^a,b   Iskandrian, Ami E ^c  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^b Medical Center Research Service   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882526621     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-05796-7.00015-1     Document Type: Chapter

References (177)

1. Hendel R.C., Jamil T., Glover D.K. Pharmacologic stress testing: New methods and new agents. J Nucl Cardiol 2003, 10:197-204.
2. Orlandi C. Pharmacology of coronary vasodilation: a brief review. J Nuc Cardiol 1996, 3:S27-S30.
3. Zoghbi G., Iskandrian A.E. Chapter 16: Pharmacologic Stress Testing. Nuclear Cardiac Imaging: Principles and Applications 2008, 293-315. Oxford University Press, New York. E.V. Garcia, A.E. Iskandrian (Eds.).
4. Henzlova M.J., Cerqueira M.D., Mahmarian J.J., Yao S.S. Stress protocols and tracers. J Nucl Cardiol 2006, 13:e80-e90.
5. Zoghbi G.J., Iskandrian A.E. Chapter 14: Coronary Artery Disease detection: Pharmacologic Stress. Clinical Nuclear Cardiology: State of the Art and Future Directions 2005, 233-253. Mosby, Inc, Philadelphia. B.L. Zaret, G.A. Beller (Eds.).
6. Abreu A., Mahmarian J.J., Nishimura S., Boyce T.M., Verani M.S. Tolerance and safety of pharmacologic coronary vasodilation with adenosine in association with thallium-201 scintigraphy in patients with suspected coronary artery disease. J Am Coll Cardiol 1991, 18:730-735.
7. Bertolet B.D., Belardinelli L., Franco E.A., Nichols W.W., Kerensky R.A., Hill J.A. Selective attenuation by N-0861 (N6-endonorboran-2-yl-9-methyladenine) of cardiac A1 adenosine receptor-mediated effects in humans. Circulation 1996, 93:1871-1876.
8. Sato A., Terata K., Miura H., Toyama K., Loberiza F.R., Hatoum O.A., Saito T., Sakuma I., Gutterman D.D. Mechanism of vasodilation to adenosine in coronary arterioles from patients with heart disease. Am J Physiol Heart Circ Physiol 2005, 288:H1633-H1640.
9. Hendel R.C., Wackers F.J., Berman D.S., Ficaro E., Depuey E.G., Klein L., Cerqueira M. American society of nuclear cardiology consensus statement: reporting of radionuclide myocardial perfusion imaging studies. J Nucl Cardiol 2003, 10:705-708.
10. Elhendy A., Bax J.J., Poldermans D. Dobutamine stress myocardial perfusion imaging in coronary artery disease. J Nucl Med 2002, 43:1634-1646.
11. Geleijnse M.L., Elhendy A., Fioretti P.M., Roelandt J.R. Dobutamine stress myocardial perfusion imaging. J Am Coll Cardiol 2000, 36:2017-2027.
12. Meuwissen M., Siebes M., Chamuleau S.A., van Eck-Smit B.L., Koch K.T., de Winter R.J., Tijssen J.G., Spaan J.A., Piek J.J. Hyperemic stenosis resistance index for evaluation of functional coronary lesion severity. Circulation 2002, 106:441-446.
13. Ogilby J.D. Role of adenosine in the cardiac catheterization laboratory. Am J Cardiol 1997, 79:15-19.
14. Chareonthaitawee P., Kaufmann P.A., Rimoldi O., Camici P.G. Heterogeneity of resting and hyperemic myocardial blood flow in healthy humans. Cardiovasc Res 2001, 50:151-161.
15. Czernin J., Muller P., Chan S., Brunken R.C., Porenta G., Krivokapich J., Chen K., Chan A., Phelps M.E., Schelbert H.R. Influence of age and hemodynamics on myocardial blood flow and flow reserve. Circulation 1993, 88:62-69.
16. Kaufmann P.A., Gnecchi-Ruscone T., Schafers K.P., Luscher T.F., Camici P.G. Low density lipoprotein cholesterol and coronary microvascular dysfunction in hypercholesterolemia. J Am Coll Cardiol 2000, 36:103-109.
17. Yokoyama I., Momomura S., Ohtake T., Yonekura K., Nishikawa J., Sasaki Y., Omata M. Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 1997, 30:1472-1477.
18. Wilson R.F., Wyche K., Christensen B.V., Zimmer S., Laxson D.D. Effects of adenosine on human coronary arterial circulation. Circulation 1990, 82:1595-1606.
19. Rossen J.D., Quillen J.E., Lopez A.G., Stenberg R.G., Talman C.L., Winniford M.D. Comparison of coronary vasodilation with intravenous dipyridamole and adenosine. J Am Coll Cardiol 1991, 18:485-491.
20. Chan S.Y., Brunken R.C., Czernin J., Porenta G., Kuhle W., Krivokapich J., Phelps M.E., Schelbert H.R. Comparison of maximal myocardial blood flow during adenosine infusion with that of intravenous dipyridamole in normal men. J Am Coll Cardiol 1992, 20:979-985.
21. Czernin J., Auerbach M., Sun K.T., Phelps M., Schelbert H.R. Effects of modified pharmacologic stress approaches on hyperemic myocardial blood flow. J Nucl Med 1995, 36:575-580.
22. Krivokapich J., Huang S.C., Schelbert H.R. Assessment of the effects of dobutamine on myocardial blood flow and oxidative metabolism in normal human subjects using nitrogen-13 ammonia and carbon-11 acetate. Am J Cardiol 1993, 71:1351-1356.
23. Skopicki H.A., Abraham S.A., Picard M.H., Alpert N.M., Fischman A.J., Gewirtz H. Effects of dobutamine at maximally tolerated dose on myocardial blood flow in humans with ischemic heart disease. Circulation 1997, 96:3346-3352.
24. Tadamura E., Iida H., Matsumoto K., Mamede M., Kubo S., Toyoda H., Shiozaki T., Mukai T., Magata Y., Konishi J. Comparison of myocardial blood flow during dobutamine-atropine infusion with that after dipyridamole administration in normal men. J Am Coll Cardiol 2001, 37:130-136.
25. Muller P., Czernin J., Choi Y., Aguilar F., Nitzsche E.U., Buxton D.B., Sun K., Phelps M.E., Huang S.C., Schelbert H.R. Effect of exercise supplementation during adenosine infusion on hyperemic blood flow and flow reserve. Am Heart J 1994, 128:52-60.
26. Beller G.A., Zaret B.L. Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease. Circulation 2000, 101:1465-1478.
27. Gould K.L. Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilatation. I. Physiologic basis and experimental validation. Am J Cardiol 1978, 41:267-278.
28. Uren N.G., Melin J.A., De Bruyne B., Wijns W., Baudhuin T., Camici P.G. Relation between myocardial blood flow and the severity of coronary-artery stenosis. N Engl J Med 1994, 330:1782-1788.
29. Wilson R.F., Marcus M.L., White C.W. Prediction of the physiologic significance of coronary arterial lesions by quantitative lesion geometry in patients with limited coronary artery disease. Circulation 1987, 75:723-732.
30. Krivokapich J., Czernin J., Schelbert H.R. Dobutamine positron emission tomography: absolute quantitation of rest and dobutamine myocardial blood flow and correlation with cardiac work and percent diameter stenosis in patients with and without coronary artery disease. J Am Coll Cardiol 1996, 28:565-572.
31. Jagathesan R., Barnes E., Rosen S.D., Foale R.A., Camici P.G. Comparison of myocardial blood flow and coronary flow reserve during dobutamine and adenosine stress: Implications for pharmacologic stress testing in coronary artery disease. J Nucl Cardiol 2006, 13:324-332.
32. Kaul S. The role of capillaries in determining coronary blood flow reserve: Implications for stress-induced reversible perfusion defects. J Nucl Cardiol 2001, 8:694-700.
33. Okada R.D., Glover D.K., Nguyen K.N., Johnson G. Technetium-99m sestamibi kinetics in reperfused canine myocardium. Eur J Nucl Med 1995, 22:600-607.
34. Voudris V., Manginas A., Vassilikos V., Koutelou M., Kantzis J., Cokkinos D.V. Coronary flow velocity changes after intravenous dipyridamole infusion: measurements using intravascular Doppler guide wire. A documentation of flow inhomogeneity. J Am Coll Cardiol 1996, 27:1148-1155.
35. Deychak Y.A., Segal J., Reiner J.S., Rohrbeck S.C., Thompson M.A., Lundergan C.F., Ross A.M., Wasserman A.G. Doppler guide wire flow-velocity indexes measured distal to coronary stenoses associated with reversible thallium perfusion defects. Am Heart J 1995, 129:219-227.
36. Ogilby J.D., Iskandrian A.S., Untereker W.J., Heo J., Nguyen T.N., Mercuro J. Effect of intravenous adenosine infusion on myocardial perfusion and function, Hemodynamic/angiographic and scintigraphic study. Circulation 1992, 86:887-895.
37. Boger L.A., Volker L.L., Hertenstein G.K., Bateman T.M. Best patient preparation before and during radionuclide myocardial perfusion imaging studies. J Nucl Cardiol 2006, 13:98-110.
38. Hansen C.L., Goldstein R.A., Berman D.S., Churchwell K.B., Cooke C.D., Corbett J.R., Cullom S.J., Dahlberg S.T., Galt J.R., Garg R.K., Heller G.V., Hyun M.C., Johnson L.L., Mann A., McCallister B.D., Taillefer R., Ward R.P. Myocardial perfusion and function SPECT. J Nucl Cardiol 2006, 13:e89-114.
39. Tadehara F., Yamamoto H., Tsujiyama S., Hinoi T., Matsuo S., Matsumoto N., Sato Y., Kohno N. Feasibility of a rapid protocol of 1-day single-isotope rest/adenosine stress Tc-99m sestamibi ECG-gated myocardial perfusion imaging. J Nucl Cardiol 2008, 15:35-41.
40. Elhendy A., van Domburg R.T., Bax J.J., Nierop P.R., Valkema R., Geleijnse M.L., Kasprzak J.D., Liqui-Lung A.F., Cornel J.H., Roelandt J.R. Dobutamine-atropine stress myocardial perfusion SPECT imaging in the diagnosis of graft stenosis after coronary artery bypass grafting. J Nucl Cardiol 1998, 5:491-497.
41. Cerqueira M.D., Verani M.S., Schwaiger M., Heo J., Iskandrian A.S. Safety profile of adenosine stress perfusion imaging: results from the Adenoscan Multicenter Trial Registry. J Am Coll Cardiol 1994, 23:384-389.
42. Ranhosky A., Kempthorne-Rawson J. The safety of intravenous dipyridamole thallium myocardial perfusion imaging. Intravenous Dipyridamole Thallium Imaging Study Group. Circulation 1990, 81:1205-1209.
43. Iskandrian A.S. Adenosine myocardial perfusion imaging. J Nucl Med 1994, 35:734-736.
44. Taillefer R., Amyot R., Turpin S., Lambert R., Pilon C., Jarry M. Comparison between dipyridamole and adenosine as pharmacologic coronary vasodilators in detection of coronary artery disease with thallium 201 imaging. J Nucl Cardiol 1996, 3:204-211.
45. Crea F., Pupita G., Galassi A.R., el-Tamimi H., Kaski J.C., Davies G., Maseri A. Role of adenosine in pathogenesis of anginal pain. Circulation 1990, 81:164-172.
46. Balan K.K., Critchley M. Is the dyspnea during adenosine cardiac stress test caused by bronchospasm?. Am Heart J 2001, 142:142-145.
47. Johnston D.L., Scanlon P.D., Hodge D.O., Glynn R.B., Hung J.C., Gibbons R.J. Pulmonary function monitoring during adenosine myocardial perfusion scintigraphy in patients with chronic obstructive pulmonary disease. Mayo Clin Proc 1999, 74:339-346.
48. Alkoutami G.S., Reeves W.C., Movahed A. The safety of adenosine pharmacologic stress testing in patients with first-degree atrioventricular block in the presence and absence of atrioventricular blocking medications. J Nucl Cardiol 1999, 6:495-497.
49. Alkoutami G.S., Reeves W.C., Movahed A. The frequency of atrioventricular block during adenosine stress testing in young, middle-aged, young-old, and old-old adults. Am J Geriatr Cardiol 2001, 10:159-161.
50. Samuels B., Kiat H., Friedman J.D., Berman D.S. Adenosine pharmacologic stress myocardial perfusion tomographic imaging in patients with significant aortic stenosis. Diagnostic efficacy and comparison of clinical, hemodynamic and electrocardiographic variables with 100 age-matched control subjects. J Am Coll Cardiol 1995, 25:99-106.
51. Lette J., Tatum J.L., Fraser S., Miller D.D., Waters D.D., Heller G., Stanton E.B., Bom H.S., Leppo J., Nattel S. Safety of dipyridamole testing in 73,806 patients: the Multicenter Dipyridamole Safety Study. J Nucl Cardiol 1995, 2:3-17.
52. Cerqueira M.D., Lawrence A. Nuclear cardiology update. Radiol Clin North Am 2001, 39:931-946. vii-viii.
53. Dakik H.A., Vempathy H., Verani M.S. Tolerance, hemodynamic changes, and safety of dobutamine stress perfusion imaging. J Nucl Cardiol 1996, 3:410-414.
54. Elhendy A., Valkema R., van Domburg R.T., Bax J.J., Nierop P.R., Cornel J.H., Geleijnse M.L., Reijs A.E., Krenning E.P., Roelandt J.R. Safety of dobutamine-atropine stress myocardial perfusion scintigraphy. J Nucl Med 1998, 39:1662-1666.
55. Lee J.H., Abuannadi M., Jones P.G., Bateman T., Thompson R., O'Keefe J.H. Dobutamine-induced chest pain does not predict ischemic findings on myocardial perfusion imaging. J Nucl Cardiol 2008, 15:526-529.
56. Mahmarian J.J., Verani M.S. Myocardial perfusion imaging during pharmacologic stress testing. Cardiol Clin 1994, 12:223-245.
57. Bravo P.E., Hage F.G., Woodham R.M., Heo J., Iskandrian A.E. Heart rate response to adenosine in patients with diabetes mellitus and normal myocardial perfusion imaging. Am J Cardiol 2008, 102:1103-1106.
58. Aksut S.V., Pancholy S., Cassel D., Cave V., Heo J., Iskandrian A.S. Results of adenosine single photon emission computed tomography thallium-201 imaging in hemodynamic nonresponders. Am Heart J 1995, 130:67-70.
59. Amanullah A.M., Berman D.S., Kiat H., Friedman J.D. Usefulness of hemodynamic changes during adenosine infusion in predicting the diagnostic accuracy of adenosine technetium-99m sestamibi single-photon emission computed tomography (SPECT). Am J Cardiol 1997, 79:1319-1322.
60. Hays J.T., Mahmarian J.J., Cochran A.J., Verani M.S. Dobutamine thallium-201 tomography for evaluating patients with suspected coronary artery disease unable to undergo exercise or vasodilator pharmacologic stress testing. J Am Coll Cardiol 1993, 21:1583-1590.
61. Iskandrian A.S. Myocardial ischemia during pharmacological stress testing. Circulation 1993, 87:1415-1417.
62. Nishimura S., Kimball K.T., Mahmarian J.J., Verani M.S. Angiographic and hemodynamic determinants of myocardial ischemia during adenosine thallium-201 scintigraphy in coronary artery disease. Circulation 1993, 87:1211-1219.
63. Werner G.S., Fritzenwanger M., Prochnau D., Schwarz G., Ferrari M., Aarnoudse W., Pijls N.H., Figulla H.R. Determinants of coronary steal in chronic total coronary occlusions donor artery, collateral, and microvascular resistance. J Am Coll Cardiol 2006, 48:51-58.
64. Chambers C.E., Brown K.A. Dipyridamole-induced ST segment depression during thallium-201 imaging in patients with coronary artery disease: angiographic and hemodynamic determinants. J Am Coll Cardiol 1988, 12:37-41.
65. Iskandrian A.E., Heo J. Myocardial perfusion imaging during adenosine-induced coronary hyperemia. Am J Cardiol 1997, 79:20-24.
66. Gulati M., Pratap P., Kansal P., Calvin J.E., Hendel R.C. Gender differences in the value of ST-segment depression during adenosine stress testing. Am J Cardiol 2004, 94:997-1002.
67. Amanullah A.M., Aasa M. Significance of ST segment depression during adenosine-induced coronary hyperemia in angina pectoris and correlation with angiographic, scintigraphic, hemodynamic, and echocardiographic variables. Int J Cardiol 1995, 48:167-176.
68. Marshall E.S., Raichlen J.S., Kim S.M., Intenzo C.M., Sawyer D.T., Brody E.A., Tighe D.A., Park C.H. Prognostic significance of ST-segment depression during adenosine perfusion imaging. Am Heart J 1995, 130:58-66.
69. Abbott B.G., Afshar M., Berger A.K., Wackers F.J. Prognostic significance of ischemic electrocardiographic changes during adenosine infusion in patients with normal myocardial perfusion imaging. J Nucl Cardiol 2003, 10:9-16.
70. Hage F.G., Dubovsky E.V., Heo J., Iskandrian A.E. Outcome of patients with adenosine-induced ST-segment depression but with normal perfusion on tomographic imaging. Am J Cardiol 2006, 98:1009-1011.
71. Klodas E., Miller T.D., Christian T.F., Hodge D.O., Gibbons R.J. Prognostic significance of ischemic electrocardiographic changes during vasodilator stress testing in patients with normal SPECT images. J Nucl Cardiol 2003, 10:4-8.
72. Verani M.S. Pharmacologic stress myocardial perfusion imaging. Curr Probl Cardiol 1993, 18:481-525.
73. Kumar S.P., Brewington S.D., O'Brien K.F., Movahed A. Clinical correlation between increased lung to heart ratio of tecnetium-99m sestamibi and multivessel coronary artery disease. Int J Cardiol 2005, 101:219-222.
74. Hansen C.L., Cen P., Sanchez B., Robinson R. Comparison of pulmonary uptake with transient cavity dilation after dipyridamole Tl-201 perfusion imaging. J Nucl Cardiol 2002, 9:47-51.
75. McLaughlin M.G., Danias P.G. Transient ischemic dilation: a powerful diagnostic and prognostic finding of stress myocardial perfusion imaging. J Nucl Cardiol 2002, 9:663-667.
76. Mazzanti M., Germano G., Kiat H., Kavanagh P.B., Alexanderson E., Friedman J.D., Hachamovitch R., Van Train K.F., Berman D.S. Identification of severe and extensive coronary artery disease by automatic measurement of transient ischemic dilation of the left ventricle in dual-isotope myocardial perfusion SPECT. J Am Coll Cardiol 1996, 27:1612-1620.
77. Abidov A., Bax J.J., Hayes S.W., Hachamovitch R., Cohen I., Gerlach J., Kang X., Friedman J.D., Germano G., Berman D.S. Transient ischemic dilation ratio of the left ventricle is a significant predictor of future cardiac events in patients with otherwise normal myocardial perfusion SPECT. J Am Coll Cardiol 2003, 42:1818-1825.
78. Abidov A., Berman D.S. Transient ischemic dilation associated with poststress myocardial stunning of the left ventricle in vasodilator stress myocardial perfusion SPECT: true marker of severe ischemia?. J Nucl Cardiol 2005, 12:258-260.
79. Emmett L., Magee M., Freedman S.B., Van der Wall H., Bush V., Trieu J., Van Gaal W., Allman K.C., Kritharides L. The role of left ventricular hypertrophy and diabetes in the presence of transient ischemic dilation of the left ventricle on myocardial perfusion SPECT images. J Nucl Med 2005, 46:1596-1601.
80. Hung G.U., Lee K.W., Chen C.P., Lin W.Y., Yang K.T. Relationship of transient ischemic dilation in dipyridamole myocardial perfusion imaging and stress-induced changes of functional parameters evaluated by Tl-201 gated SPECT. J Nucl Cardiol 2005, 12:268-275.
81. Chouraqui P., Rodrigues E.A., Berman D.S., Maddahi J. Significance of dipyridamole-induced transient dilation of the left ventricle during thallium-201 scintigraphy in suspected coronary artery disease. Am J Cardiol 1990, 66:689-694.
82. Takeishi Y., Tono-oka I., Ikeda K., Komatani A., Tsuiki K., Yasui S. Dilatation of the left ventricular cavity on dipyridamole thallium-201 imaging: a new marker of triple-vessel disease. Am Heart J 1991, 121:466-475.
83. Tanaka H., Chikamori T., Hida S., Usui Y., Harafuji K., Igarashi Y., Yamashina A. Comparison of post-exercise and post-vasodilator stress myocardial stunning as assessed by electrocardiogram-gated single-photon emission computed tomography. Circ J 2005, 69:1338-1345.
84. Ward R.P., Gundeck E.L., Lang R.M., Spencer K.T., Williams K.A. Overestimation of postischemic myocardial stunning on gated SPECT imaging: correlation with echocardiography. J Nucl Cardiol 2006, 13:514-520.
85. D'Antono B., Dupuis G., Fortin C., Arsenault A., Burelle D. Detection of exercise-induced myocardial ischemia from symptomatology experienced during testing in men and women. Can J Cardiol 2006, 22:411-417.
86. Hung G.U., Lee K.W., Chen C.P., Yang K.T., Lin W.Y. Worsening of left ventricular ejection fraction induced by dipyridamole on Tl-201 gated myocardial perfusion imaging predicts significant coronary artery disease. J Nucl Cardiol 2006, 13:225-232.
87. Druz R.S., Akinboboye O.A., Grimson R., Nichols K.J., Reichek N. Postischemic stunning after adenosine vasodilator stress. J Nucl Cardiol 2004, 11:534-541.
88. Ohtaki Y., Chikamori T., Igarashi Y., Hida S., Tanaka H., Hatano T., Usui Y., Miyagi M., Yamashina A. Differential effects comparing exercise and pharmacologic stress on left ventricular function using gated Tc-99m sestamibi SPECT. Ann Nucl Med 2008, 22:185-190.
89. Brinkman N., Dibbets-Schneider P., Scholte A.J., Stokkel M.P. Myocardial perfusion scintigraphy with adenosine: does it impair the left ventricular ejection fraction obtained with gated SPECT?. Clin Nucl Med 2008, 33:89-93.
90. Pijls N.H., De Bruyne B., Peels K., Van Der Voort P.H., Bonnier H.J., Bartunek J.K.J.J., Koolen J.J. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 1996, 334:1703-1708.
91. Rodes-Cabau J., Candell-Riera J., Angel J., de Leon G., Pereztol O., Castell-Conesa J., Soto A., Anivarro I., Aguade S., Vazquez M., Domingo E., Tardif J.C., Soler-Soler J. Relation of myocardial perfusion defects and nonsignificant coronary lesions by angiography with insights from intravascular ultrasound and coronary pressure measurements. Am J Cardiol 2005, 96:1621-1626.
92. Klocke F.J., Baird M.G., Lorell B.H., Bateman T.M., Messer J.V., Berman D.S., O'Gara P.T., Carabello B.A., Russell R.O., Cerqueira M.D., St John Sutton M.G., DeMaria A.N., Udelson J.E., Kennedy J.W., Verani M.S., Williams K.A., Antman E.M., Smith S.C., Alpert J.S., Gregoratos G., Anderson J.L., Hiratzka L.F., Faxon D.P., Hunt S.A., Fuster V., Jacobs A.K., Gibbons R.J., Russell R.O. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). J Am Coll Cardiol 2003, 42:1318-1333.
93. Johansen A., Hoilund-Carlsen P.F., Christensen H.W., Vach W., Jorgensen H.B., Veje A., Haghfelt T. Diagnostic accuracy of myocardial perfusion imaging in a study population without post-test referral bias. J Nucl Cardiol 2005, 12:530-537.
94. Kim C., Kwok Y.S., Heagerty P., Redberg R. Pharmacologic stress testing for coronary disease diagnosis: A meta-analysis. Am Heart J 2001, 142:934-944.
95. Tartagni F., Dondi M., Limonetti P., Franchi R., Maiello L., Monetti N., Magnani B. Dipyridamole technetium-99m-2-methoxy isobutyl isonitrile tomoscintigraphic imaging for identifying diseased coronary vessels: comparison with thallium-201 stress-rest study. J Nucl Med 1991, 32:369-376.
96. Soman P., Taillefer R., DePuey E.G., Udelson J.E., Lahiri A. Enhanced detection of reversible perfusion defects by Tc-99m sestamibi compared to Tc-99m tetrofosmin during vasodilator stress SPECT imaging in mild-to-moderate coronary artery disease. J Am Coll Cardiol 2001, 37:458-462.
97. Berman D.S., Kang X., Hayes S.W., Friedman J.D., Cohen I., Abidov A., Shaw L.J., Amanullah A.M., Germano G., Hachamovitch R. Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men. Impact of diabetes mellitus on incremental prognostic value and effect on patient management. J Am Coll Cardiol 2003, 41:1125-1133.
98. Nishina H., Slomka P.J., Abidov A., Yoda S., Akincioglu C., Kang X., Cohen I., Hayes S.W., Friedman J.D., Germano G., Berman D.S. Combined Supine and Prone Quantitative Myocardial Perfusion SPECT: Method Development and Clinical Validation in Patients with No Known Coronary Artery Disease. J Nucl Med 2006, 47:51-58.
99. Wright D.J., Williams S.G., Lindsay H.S., Sheard K.L., Thorley P.J., Sivananthan U.M. Assessment of adenosine, arbutamine and dobutamine as pharmacological stress agents during (99m)Tc-tetrofosmin SPECT imaging: a randomized study. Nucl Med Commun 2001, 22:1305-1311.
100. Coyne E.P., Belvedere D.A., Vande Streek P.R., Weiland F.L., Evans R.B., Spaccavento L.J. Thallium-201 scintigraphy after intravenous infusion of adenosine compared with exercise thallium testing in the diagnosis of coronary artery disease. J Am Coll Cardiol 1991, 17:1289-1294.
101. Gupta N.C., Esterbrooks D.J., Hilleman D.E., Mohiuddin S.M. Comparison of adenosine and exercise thallium-201 single-photon emission computed tomography (SPECT) myocardial perfusion imaging. The GE SPECT Multicenter Adenosine Study Group. J Am Coll Cardiol 1992, 19:248-257.
102. Nishimura S., Mahmarian J.J., Boyce T.M., Verani M.S. Equivalence between adenosine and exercise thallium-201 myocardial tomography: a multicenter, prospective, crossover trial. J Am Coll Cardiol 1992, 20:265-275.
103. Cuocolo A., Soricelli A., Pace L., Nicolai E., Castelli L., Nappi A., Imbriaco M., Morisco C., Ell P.J., Salvatore M. Adenosine technetium-99m-methoxy isobutyl isonitrile myocardial tomography in patients with coronary artery disease: comparison with exercise. J Nucl Med 1994, 35:1110-1115.
104. Vallejo E., Morales M., Sanchez I., Sanchez G., Alburez J.C., Bialostozky D. Myocardial perfusion SPECT imaging in patients with myocardial bridging. J Nucl Cardiol 2005, 12:318-323.
105. Chow B.J., Beanlands R.S., Lee A., DaSilva J.N., deKemp R.A., Alkahtani A., Ruddy T.D. Treadmill exercise produces larger perfusion defects than dipyridamole stress N-13 ammonia positron emission tomography. J Am Coll Cardiol 2006, 47:411-416.
106. Santos-Ocampo C.D., Herman S.D., Travin M.I., Garber C.E., Ahlberg A.W., Messinger D.E., Heller G.V. Comparison of exercise, dipyridamole, and adenosine by use of technetium 99m sestamibi tomographic imaging. J Nucl Cardiol 1994, 1:57-64.
107. Levine M.G., Ahlberg A.W., Mann A., White M.P., McGill C.C., Mendes de Leon C., Piriz J.M., Waters D., Heller G.V. Comparison of exercise, dipyridamole, adenosine, and dobutamine stress with the use of Tc-99m tetrofosmin tomographic imaging. J Nucl Cardiol 1999, 6:389-396.
108. Mieres J.H., Shaw L.J. Stress myocardial perfusion imaging in the diagnosis and prognosis of women with suspected coronary artery disease. Cardiol Rev 2003, 11:330-336.
109. Elhendy A., Schinkel A.F., Bax J.J., van Domburg R.T., Valkema R., Biagini E., Feringa H.H., Poldermans D. Accuracy of stress Tc-99m tetrofosmin myocardial perfusion tomography for the diagnosis and localization of coronary artery disease in women. J Nucl Cardiol 2006, 13:629-634.
110. Shaw L.J., Bairey Merz C.N., Pepine C.J., Reis S.E., Bittner V., Kelsey S.F., Olson M., Johnson B.D., Mankad S., Sharaf B.L., Rogers W.J., Wessel T.R., Arant C.B., Pohost G.M., Lerman A., Quyyumi A.A., Sopko G. Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J Am Coll Cardiol 2006, 47:S4-S20.
111. Amanullah A.M., Kiat H., Friedman J.D., Berman D.S. Adenosine technetium-99m sestamibi myocardial perfusion SPECT in women: diagnostic efficacy in detection of coronary artery disease. J Am Coll Cardiol 1996, 27:803-809.
112. Iskandrian A.E., Heo J., Nallamothu N. Detection of coronary artery disease in women with use of stress single-photon emission computed tomography myocardial perfusion imaging. J Nucl Cardiol 1997, 4:329-335.
113. Taillefer R., DePuey E.G., Udelson J.E., Beller G.A., Latour Y., Reeves F. Comparative diagnostic accuracy of Tl-201 and Tc-99m sestamibi SPECT imaging (perfusion and ECG-gated SPECT) in detecting coronary artery disease in women. J Am Coll Cardiol 1997, 29:69-77.
114. Iskandrian A.S., Heo J., Lemlek J., Ogilby J.D., Untereker W.J., Iskandrian B., Cave V. Identification of high-risk patients with left main and three-vessel coronary artery disease by adenosine-single photon emission computed tomographic thallium imaging. Am Heart J 1993, 125:1130-1135.
115. Ho K.T., Miller T.D., Christian T.F., Hodge D.O., Gibbons R.J. Prediction of severe coronary artery disease and long-term outcome in patients undergoing vasodilator SPECT. J Nucl Cardiol 2001, 8:438-444.
116. Amanullah A.M., Berman D.S., Hachamovitch R., Kiat H., Kang X., Friedman J.D. Identification of severe or extensive coronary artery disease in women by adenosine technetium-99m sestamibi SPECT. Am J Cardiol 1997, 80:132-137.
117. Berman D.S., Kang X., Slomka P.J., Gerlach J., de Yang L., Hayes S.W., Friedman J.D., Thomson L.E., Germano G. Underestimation of extent of ischemia by gated SPECT myocardial perfusion imaging in patients with left main coronary artery disease. J Nucl Cardiol 2007, 14:521-528.
118. Villegas B.J., Hendel R.C., Dahlberg S.T., McSherry B.A., Leppo J.A. Comparison of 3- versus 6-minute infusions of adenosine in thallium-201 myocardial perfusion imaging. Am Heart J 1993, 126:103-107.
119. Treuth M.G., Reyes G.A., He Z.X., Cwajg E., Mahmarian J.J., Verani M.S. Tolerance and diagnostic accuracy of an abbreviated adenosine infusion for myocardial scintigraphy: a randomized, prospective study. J Nucl Cardiol 2001, 8:548-554.
120. O'Keefe J.H., Bateman T.M., Handlin L.R., Barnhart C.S. Four- versus 6-minute infusion protocol for adenosine thallium-201 single photon emission computed tomography imaging. Am Heart J 1995, 129:482-487.
121. Elliott M.D., Holly T.A., Leonard S.M., Hendel R.C. Impact of an abbreviated adenosine protocol incorporating adjunctive treadmill exercise on adverse effects and image quality in patients undergoing stress myocardial perfusion imaging. J Nucl Cardiol 2000, 7:584-589.
122. Pennell D.J., Mavrogeni S.I., Forbat S.M., Karwatowski S.P., Underwood S.R. Adenosine combined with dynamic exercise for myocardial perfusion imaging. J Am Coll Cardiol 1995, 25:1300-1309.
123. Samady H., Wackers F.J., Joska T.M., Zaret B.L., Jain D. Pharmacologic stress perfusion imaging with adenosine: role of simultaneous low-level treadmill exercise. J Nucl Cardiol 2002, 9:188-196.
124. Thomas G.S., Prill N.V., Majmundar H., Fabrizi R.R., Thomas J.J., Hayashida C., Kothapalli S., Payne J.L., Payne M.M., Miyamoto M.I. Treadmill exercise during adenosine infusion is safe, results in fewer adverse reactions, and improves myocardial perfusion image quality. J Nucl Cardiol 2000, 7:439-446.
125. Casale P.N., Guiney T.E., Strauss H.W., Boucher C.A. Simultaneous low level treadmill exercise and intravenous dipyridamole stress thallium imaging. Am J Cardiol 1988, 62:799-802.
126. Ignaszewski A.P., McCormick L.X., Heslip P.G., McEwan A.J., Humen D.P. Safety and clinical utility of combined intravenous dipyridamole/symptom-limited exercise stress test with thallium-201 imaging in patients with known or suspected coronary artery disease. J Nucl Med 1993, 34:2053-2061.
127. Holly T.A., Satran A., Bromet D.S., Mieres J.H., Frey M.J., Elliott M.D., Heller G.V., Hendel R.C. The impact of adjunctive adenosine infusion during exercise myocardial perfusion imaging: Results of the Both Exercise and Adenosine Stress Test (BEAST) trial. J Nucl Cardiol 2003, 10:291-296.
128. Thomas G.S., Miyamoto M.I. Should simultaneous exercise become the standard for adenosine myocardial perfusion imaging?. Am J Cardiol 2004, 94:3D-10D. discussion 10D-11D.
129. Shehata A.R., Ahlberg A.W., White M.P., Mann A., Fleming I.A., Levine M.G., Mather J.F., Waters D., Heller G.V. Dipyridamole-dobutamine stress with Tc-99m sestamibi tomographic myocardial perfusion imaging. Am J Cardiol 1998, 82:520-523.
130. Aydin M., Caner B., Yildirir A., Sari O., Tokgozoglu L. Dobutamine combined with low-level exercise for myocardial perfusion scintigraphy. Nucl Med Commun 2000, 21:1015-1020.
131. Bokhari S., Pinsky D.J., Bergmann S.R. An improved dobutamine protocol for myocardial perfusion imaging. Am J Cardiol 2001, 88:1303-1305.
132. Nadig M.R., Patel C.D., Malhotra A. Comparison between dobutamine stress and combination of handgrip exercise with dobutamine stress in myocardial perfusion SPECT. Nucl Med Commun 2007, 28:301-304.
133. Leao Lima Rde S., De Lorenzo A., Issa A. Reduced adverse effects with an accelerated dobutamine stress protocol compared with the conventional protocol: a prospective, randomized myocardial perfusion scintigraphy study. Int J Cardiovasc Imaging 2008, 24:55-59.
134. Skalidis E.I., Kochiadakis G.E., Koukouraki S.I., Parthenakis F.I., Karkavitsas N.S., Vardas P.E. Phasic coronary flow pattern and flow reserve in patients with left bundle branch block and normal coronary arteries. J Am Coll Cardiol 1999, 33:1338-1346.
135. O'Keefe J.H., Bateman T.M., Barnhart C.S. Adenosine thallium-201 is superior to exercise thallium-201 for detecting coronary artery disease in patients with left bundle branch block. J Am Coll Cardiol 1993, 21:1332-1338.
136. Feola M., Biggi A., Vado A., Ribichini F., Ferrero V., Leonardi G., Uslenghi E. The usefulness of adenosine 99mTc tetrofosmin SPECT for the diagnosis of left anterior descending coronary artery disease in patients with chest pain and left bundle branch block. Nucl Med Commun 2004, 25:265-269.
137. Hoefflinghaus T., Husmann L., Valenta I., Moonen C., Gaemperli O., Schepis T., Namdar M., Koepfli P., Siegrist P.T., Kaufmann P.A. Role of attenuation correction to discriminate defects caused by left bundle branch block versus coronary stenosis in single photon emission computed tomography myocardial perfusion imaging. Clin Nucl Med 2008, 33:748-751.
138. Tse H.F., Lau C.P. Long-term effect of right ventricular pacing on myocardial perfusion and function. J Am Coll Cardiol 1997, 29:744-749.
139. Tse H.F., Yu C., Wong K.K., Tsang V., Leung Y.L., Ho W.Y., Lau C.P. Functional abnormalities in patients with permanent right ventricular pacing: the effect of sites of electrical stimulation. J Am Coll Cardiol 2002, 40:1451-1458.
140. Lakkis N.M., He Z.X., Verani M.S. Diagnosis of coronary artery disease by exercise thallium-201 tomography in patients with a right ventricular pacemaker. J Am Coll Cardiol 1997, 29:1221-1225.
141. DePuey E.G., Guertler-Krawczynska E., Perkins J.V., Robbins W.L., Whelchel J.D., Clements S.D. Alterations in myocardial thallium-201 distribution in patients with chronic systemic hypertension undergoing single-photon emission computed tomography. Am J Cardiol 1988, 62:234-238.
142. Houghton J.L., Prisant L.M., Carr A.A., Flowers N.C., Frank M.J. Racial differences in myocardial ischemia and coronary flow reserve in hypertension. J Am Coll Cardiol 1994, 23:1123-1129.
143. Vaduganathan P., He Z.X., Mahmarian J.J., Verani M.S. Diagnostic accuracy of stress thallium-201 tomography in patients with left ventricular hypertrophy. Am J Cardiol 1998, 81:1205-1207.
144. Elhendy A., van Domburg R.T., Sozzi F.B., Poldermans D., Bax J.J., Roelandt J.R. Impact of hypertension on the accuracy of exercise stress myocardial perfusion imaging for the diagnosis of coronary artery disease. Heart 2001, 85:655-661.
145. Yao S.S., Qureshi E., Nichols K., Diamond G.A., Depuey E.G., Rozanski A. Prospective validation of a quantitative method for differentiating ischemic versus nonischemic cardiomyopathy by technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. Clin Cardiol 2004, 27:615-620.
146. Her S.H., Yoon H.J., Lee J.M., Jin S.W., Youn H.J., Seung K.B., Kim J.H. Adenosine Tc-99m tetrofosmin SPECT in differentiation of ischemic from nonischemic cardiomyopathy in patients with LV systolic dysfunction. Clin Nucl Med 2008, 33:459-463.
147. Zoghbi G.J., Dorfman T.A., Iskandrian A.E. The effects of medications on myocardial perfusion. J Am Coll Cardiol 2008, 52:401-416.
148. Sharir T., Rabinowitz B., Livschitz S., Moalem I., Baron J., Kaplinsky E., Chouraqui P. Underestimation of extent and severity of coronary artery disease by dipyridamole stress thallium-201 single-photon emission computed tomographic myocardial perfusion imaging in patients taking antianginal drugs. J Am Coll Cardiol 1998, 31:1540-1546.
149. Koepfli P., Wyss C.A., Namdar M., Klainguti M., von Schulthess G.K., Luscher T.F., Kaufmann P.A. Beta-adrenergic blockade and myocardial perfusion in coronary artery disease: differential effects in stenotic versus remote myocardial segments. J Nucl Med 2004, 45:1626-1631.
150. Shehata A.R., Gillam L.D., Mascitelli V.A., Herman S.D., Ahlberg A.W., White M.P., Chen C., Waters D.D., Heller G.V. Impact of acute propranolol administration on dobutamine-induced myocardial ischemia as evaluated by myocardial perfusion imaging and echocardiography. Am J Cardiol 1997, 80:268-272.
151. Bridges A.B., Kennedy N., McNeill G.P., Cook B., Pringle T.H. The effect of atenolol on dipyridamole 201Tl myocardial perfusion tomography in patients with coronary artery disease. Nucl Med Commun 1992, 13:41-46.
152. Taillefer R., Ahlberg A.W., Masood Y., White C.M., Lamargese I., Mather J.F., McGill C.C., Heller G.V. Acute beta-blockade reduces the extent and severity of myocardial perfusion defects with dipyridamole Tc-99m sestamibi SPECT imaging. J Am Coll Cardiol 2003, 42:1475-1483.
153. Lakkireddy D., Aronow W.S., Bateman T., McGhee I., Nair C., Khan I.A. Does beta blocker therapy affect the diagnostic accuracy of adenosine single-photon-emission computed tomographic myocardial perfusion imaging?. Am J Ther 2008, 15:19-23.
154. Bottcher M., Refsgaard J., Madsen M.M., Randsbaek F., Kaltoft A., Botker H.E., Nielsen T.T. Effect of antianginal medication on resting myocardial perfusion and pharmacologically induced hyperemia. J Nucl Cardiol 2003, 10:345-352.
155. Muller-Suur R., Eriksson S.V., Strandberg L.E., Mesko L. Comparison of adenosine and exercise stress test for quantitative perfusion imaging in patients on beta-blocker therapy. Cardiology 2001, 95:112-118.
156. Gould K.L., Martucci J.P., Goldberg D.I., Hess M.J., Edens R.P., Latifi R., Dudrick S.J. Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. A potential noninvasive marker of healing coronary endothelium. Circulation 1994, 89:1530-1538.
157. Mostaza J.M., Gomez M.V., Gallardo F., Salazar M.L., Martin-Jadraque R., Plaza-Celemin L., Gonzalez-Maqueda I., Martin-Jadraque L. Cholesterol reduction improves myocardial perfusion abnormalities in patients with coronary artery disease and average cholesterol levels. J Am Coll Cardiol 2000, 35:76-82.
158. Treasure C.B., Klein J.L., Weintraub W.S., Talley J.D., Stillabower M.E., Kosinski A.S., Zhang J., Boccuzzi S.J., Cedarholm J.C., Alexander R.W. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 1995, 332:481-487.
159. Schwartz R.G., Pearson T.A., Kalaria V.G., Mackin M.L., Williford D.J., Awasthi A., Shah A., Rains A., Guido J.J. Prospective serial evaluation of myocardial perfusion and lipids during the first six months of pravastatin therapy: coronary artery disease regression single photon emission computed tomography monitoring trial. J Am Coll Cardiol 2003, 42:600-610.
160. Guethlin M., Kasel A.M., Coppenrath K., Ziegler S., Delius W., Schwaiger M. Delayed response of myocardial flow reserve to lipid-lowering therapy with fluvastatin. Circulation 1999, 99:475-481.
161. Huggins G.S., Pasternak R.C., Alpert N.M., Fischman A.J., Gewirtz H. Effects of short-term treatment of hyperlipidemia on coronary vasodilator function and myocardial perfusion in regions having substantial impairment of baseline dilator reverse. Circulation 1998, 98:1291-1296.
162. Yokoyama I., Momomura S., Ohtake T., Yonekura K., Yang W., Kobayakawa N., Aoyagi T., Sugiura S., Yamada N., Ohtomo K., Sasaki Y., Omata M., Yazaki Y. Improvement of impaired myocardial vasodilatation due to diffuse coronary atherosclerosis in hypercholesterolemics after lipid-lowering therapy. Circulation 1999, 100:117-122.
163. Yokoyama I., Yonekura K., Inoue Y., Ohtomo K., Nagai R. Long-term effect of simvastatin on the improvement of impaired myocardial flow reserve in patients with familial hypercholesterolemia without gender variance. J Nucl Cardiol 2001, 8:445-451.
164. Dakik H.A., Kleiman N.S., Farmer J.A., He Z.X., Wendt J.A., Pratt C.M., Verani M.S., Mahmarian J.J. Intensive medical therapy versus coronary angioplasty for suppression of myocardial ischemia in survivors of acute myocardial infarction: a prospective, randomized pilot study. Circulation 1998, 98:2017-2023.
165. Mahmarian J.J., Dakik H.A., Filipchuk N.G., Shaw L.J., Iskander S.S., Ruddy T.D., Keng F., Henzlova M.J., Allam A., Moye L.A., Pratt C.M. An initial strategy of intensive medical therapy is comparable to that of coronary revascularization for suppression of scintigraphic ischemia in high-risk but stable survivors of acute myocardial infarction. J Am Coll Cardiol 2006, 48:2458-2467.
166. Aqel R.A., Zoghbi G.J., Trimm J.R., Baldwin S.A., Iskandrian A.E. Effect of caffeine administered intravenously on intracoronary-administered adenosine-induced coronary hemodynamics in patients with coronary artery disease. Am J Cardiol 2004, 93:343-346.
167. Zoghbi G.J., Htay T., Aqel R., Blackmon L., Heo J., Iskandrian A.E. Effect of caffeine on ischemia detection by adenosine single-photon emission computed tomography perfusion imaging. J Am Coll Cardiol 2006, 47:2296-2302.
168. Reyes E., Loong C.Y., Harbinson M., Donovan J., Anagnostopoulos C., Underwood S.R. High-dose adenosine overcomes the attenuation of myocardial perfusion reserve caused by caffeine. J Am Coll Cardiol 2008, 52:2008-2016.
169. Cerqueira M.D. Advances in pharmacologic agents in imaging: new A2A receptor agonists. Curr Cardiol Rep 2006, 8:119-122.
170. Iskandrian A.E. A new generation of coronary vasodilators in stress perfusion imaging. Am J Cardiol 2007, 99:1619-1620.
171. Hodgson J.M., Dib N., Kern M.J., Bach R.G., Barrett R.J. Coronary circulation responses to binodenoson, a selective adenosine A2A receptor agonist. Am J Cardiol 2007, 99:1507-1512.
172. Udelson J.E., Heller G.V., Wackers F.J., Chai A., Hinchman D., Coleman P.S., Dilsizian V., DiCarli M., Hachamovitch R., Johnson J.R., Barrett R.J., Gibbons R.J. Randomized, controlled dose-ranging study of the selective adenosine A2A receptor agonist binodenoson for pharmacological stress as an adjunct to myocardial perfusion imaging. Circulation 2004, 109:457-464.
173. Lieu H.D., Shryock J.C., von Mering G.O., Gordi T., Blackburn B., Olmsted A.W., Belardinelli L., Kerensky R.A. Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans. J Nucl Cardiol 2007, 14:514-520.
174. Iskandrian A.E., Bateman T.M., Belardinelli L., Blackburn B., Cerqueira M.D., Hendel R.C., Lieu H., Mahmarian J.J., Olmsted A., Underwood S.R., Vitola J., Wang W. Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial. J Nucl Cardiol 2007, 14:645-658.
175. Cerqueira M.D., Nguyen P., Steahr P., Underwood R., Iskandrian A.E. on behalf of the ADVANCE-MPI trial investigators. Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging: integrated ADVANCE-MPI trial results. JACC Cardiovasc Imaging 2008, 1:307-316.
176. Leaker B.R., O'Connor B., Hansel T.T., Barnes P.J., Meng L., Mathur V.S., Lieu H.D. Safety of regadenoson, an adenosine A2A receptor agonist for myocardial perfusion imaging, in mild asthma and moderate asthma patients: a randomized, double-blind, placebo-controlled trial. J Nucl Cardiol 2008, 15:329-336.
177. Thomas G.S., Tammelin B.R., Schiffman G.L., Marquez R., Rice D.L., Milikien D., Mathur V. Safety of regadenoson, a selective adenosine A2A agonist, in patients with chronic obstructive pulmonary disease: A randomized, double-blind, placebo-controlled trial (RegCOPD trial). J Nucl Cardiol 2008, 15:319-328.